← Back to all trials
Not Yet Recruiting
NCT07228039
ESP Blocks for Posterior Spinal Fusion
Conditions: Postoperative Pain
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 75
Sponsor: Duke University
Location: Duke University Durham North Carolina
Summary
This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outcomes include opioid consumption over 72 hours, pain scores, length of stay, and time to ambulation.
Eligibility Criteria
Inclusion Criteria
* English speaking
* Age 18-75
* ASA physical status 1-3
* Undergoing elective cervical or lumbar posterior spinal fusion (≤3 levels)
Exclusion Criteria
* Age \75
* ASA IV or V
* Non-English speaking
* BMI \>40
* Opioid dependence
* Chronic pain
* Anticoagulation or coagulopathy
* Injection site infection
* Hepatic or renal insufficiency
* Allergy to study drugs
* Pregnancy
* Inability to communicate with investigators
Source: ClinicalTrials.gov (NCT07228039). StuddyBuddy aggregates publicly available trial information.
